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Solomon Islands is intensifying national efforts to achieve malaria elimination. A long history
of indoor spraying with residual insecticides, combined recently with distribution of long last-
ing insecticidal nets and artemether-lumefantrine therapy, has been implemented in Solo-
mon Islands. The impact of these interventions on local endemicity of Plasmodium spp.
is unknown.
Methods
In 2012, a cross-sectional survey of 3501 residents of all ages was conducted in Ngella,
Central Islands Province, Solomon Islands. Prevalence of Plasmodium falciparum, P. vivax,
P. ovale and P.malariae was assessed by quantitative PCR (qPCR) and light microscopy
(LM). Presence of gametocytes was determined by reverse transcription quantitative PCR
(RT-qPCR).
Results
By qPCR, 468 Plasmodium spp. infections were detected (prevalence = 13.4%; 463 P.
vivax, five mixed P. falciparum/P. vivax, no P. ovale or P.malariae) versus 130 by LM (preva-
lence = 3.7%; 126 P. vivax, three P. falciparum and one P. falciparum/P. vivax). The preva-
lence of P. vivax infection varied significantly among villages (range 3.0–38.5%, p<0.001)
and across age groups (5.3–25.9%, p<0.001). Of 468 P. vivax infections, 72.9% were sub-
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microscopic, 84.5% afebrile and 60.0% were both sub-microscopic and afebrile. Local resi-
dency, low education level of the household head and living in a household with at least one
other P. vivax infected individual increased the risk of P. vivax infection. Overall, 23.5% of P.
vivax infections had concurrent gametocytaemia. Of all P. vivax positive samples, 29.2%
were polyclonal by MS16 andmsp1F3 genotyping. All five P. falciparum infections were de-
tected in residents of the same village, carried the samemsp2 allele and four were positive
for P. falciparum gametocytes.
Conclusion
P. vivax infection remains endemic in Ngella, with the majority of cases afebrile and below
the detection limit of LM. P. falciparum has nearly disappeared, but the risk of re-introduc-
tions and outbreaks due to travel to nearby islands with higher malaria endemicity remains.
Author Summary
Solomon Islands, an island nation in the Southwest Pacific that has seen dramatic reduc-
tions in malaria transmission over the past 20 years, is aiming for malaria elimination.
There is an increasing recognition that a substantial reservoir of asymptomatic and often
sub-microscopic Plasmodium spp. infections exists even in low transmission settings.
However, the potential role for these infections in sustaining transmission and the differ-
ence in response of the two most common malaria parasites, P. vivax and P. falciparum, to
intensified control remains unclear. In May-June 2012, we therefore performed a cross-
sectional survey of 3501 residents of all ages of Ngella, a low transmission area in Central
Islands Province, to assess the prevalence of P. vivax and P. falciparum infection, deter-
mine the proportion of sub-microscopic and afebrile infections and evaluate whether
gametocytaemic, and thus potentially infectious, individuals are present. Our survey
showed a marked epidemiological contrast between P. vivax and P. falciparum. Although
prevalence varied significantly among different regions of Ngella, P. vivax remains firmly
endemic, with high rates of sub-microscopic, afebrile and genetically diverse infections.
The presence of gametocytes among both sub-microscopic and microscopy positive,
asymptomatic infections indicates that these infections contribute significantly to sustain-
ing P. vivax transmission. P. falciparum, on the other hand, appears to be more amenable
to control interventions. Only five P. falciparum infected individuals were detected, and all
were residents of the same village. These infections carried the samemsp2 clone. This dif-
ference highlights the larger challenge of eliminating P. vivax compared to P. falciparum
in areas where they are co-endemic. In particular, the challenge posed by the presence of a
large reservoir of silent P. vivax infections will need to be addressed if control of this para-
site is to be accelerated and elimination achieved.
Introduction
Nations in the Southwest Pacific have endured considerable malaria transmission, with the
highest Plasmodium falciparum burden outside the African continent and possibly the highest
Plasmodium vivax transmission in the world [1]. Historically, transmission has ranged from
hyperendemic areas in West Papua (Indonesia) and Papua New Guinea [2] to high and
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moderate transmission in Solomon Islands and Vanuatu [3], which are the southwestern
boundary of global malaria transmission. Intensified control over the last 20 years has resulted
in remarkable declines in malaria transmission in this region [3,4], reviving the agenda of elim-
ination. However, it is in these countries where outstanding progress towards elimination has
been made, that more knowledge is needed if the vision of malaria elimination is to be realized,
such as reliable prevalence estimates, role of low-density, asymptomatic carriers and determi-
nants of transmission maintenance.
In Solomon Islands, the incidence of clinical malaria cases diagnosed by light microscopy
(LM) dropped by 90% from 442/1000 population in 1992 [5] to 44/1000 population in 2012
[6]. These drops in incidence are similar to those achieved by the Malaria Eradication Program
in Solomon Islands (1970–1975) [7]. National statistics based on passive surveillance indicate
that 65% of clinical malaria cases in 2012 were attributable to P. falciparum, 33% to P. vivax
and 2% to mixed P. falciparum/P. vivax. Conversely, active case detection surveys indicate that
P. vivax is the predominant species in the general population [6]. Current malaria transmission
appears to be focal, ranging from moderate to high levels in Honiara City (96/1000) and Gua-
dalcanal (64/1000) to very low in Temotu (10.8/1000) and Isabel provinces (1.2/1000).
Temotu and Isabel are the only two provinces in which pilot elimination agenda has been
proposed to be actively pursued, having resulted in more intensive control activities and inter-
ventions including stratification, active case detection, and the earlier roll out of control activi-
ties (e.g. rapid diagnostic tests, RDTs and indoor residual spraying) than the rest of the country
[3]. These provinces are also the only areas of Solomon Islands with recent surveys in which
both LM and PCR-based diagnoses of Plasmodium spp. infections were performed [8,9]. In
2008, a parasite prevalence of 2.7% by LM was found in Temotu, with P. vivax accounting for
82.5% of infections. Only 5.5% of these infections were associated with febrile illness. Among a
subset of 1,748 samples, which included LM positive, febrile and 10% of LM negative partici-
pants, an additional 63 P. falciparum, 23 P. vivax and 10 mixed P. falciparum/P. vivax infec-
tions were detected by PCR, indicating a 6.5% prevalence of sub-microscopic infections. Even
lower levels of infection were reported in Isabel in 2009: 1 of 8,554 participants had a LM-de-
tectable P. falciparum infection (0.01%). In a random subset of 2001 participants, PCR identi-
fied an additional 13 (0.55%) P. vivax infections.
PCR consistently detects at least twice as many infections as LM [10]. Numerous studies
have confirmed that sub-microscopic infections are a common feature of malaria endemic
areas, spanning all age groups and involving both P. falciparum and P. vivax [11–13]. Although
these sub-microscopic infections are rarely associated with febrile illness, they have been
shown to be efficient gametocyte producers [14–19] and thus constitute a source of ongoing
transmission [10].
Given the lack of data from other areas of Solomon Islands, it is currently unknown whether
the pattern of asymptomatic, low-density infection carriage identified in Temotu and Isabel
[8,9] is unique to these elimination provinces. In addition, whereas these earlier surveys de-
tected a large burden of sub-microscopic infections, they did not determine if these infections
were also gametocytaemic and therefore did not assess their potential contribution to transmis-
sion. Therefore, we conducted in May-June 2012 a household-based, cross-sectional survey in
Ngella, Central Islands Province to determine how common low-density, asymptomatic infec-
tions are in communities where transmission is mesoendemic and whether these infections are
gametocyte producers and hence, potential contributors to local transmission. This survey is
the first epidemiological description of malaria in Ngella since the 1970–1975 Malaria Eradica-
tion Program [7] and the only one in Solomon Islands to employ highly sensitive molecular di-
agnosis for the detection of both blood-stage parasites and gametocytes.
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Methods
Ethics statement
This study was approved by The Walter and Eliza Hall Institute Human Research Ethics Com-
mittee (HREC number 12/01) and the Solomon Islands National Health Research Ethics Com-
mittee (HRC12/022). The informed consent process recognized the community and cultural
values of Solomon Islands. Following consultation with and approval by community leaders,
community meetings were held to explain the aims, risks and potential benefits of the study.
Individual informed consent was obtained from all participants or the parent or legal guardian
of children<18 years of age. At the point of collection, all samples were de-identified.
Study site
Ngella, previously known as the Florida Islands, consists of 3 islands, Anchor, Big Ngella and
Small Ngella, located approximately 27 miles north of Guadalcanal and 50 miles southwest of
Malaita (Fig 1). Along with Tulaghi, Savo, Russel and Buenavista Islands it forms part of the
Central Islands Province (Fig 1). Despite their proximity, the three islands of Ngella have di-
verse geographical characteristics: Anchor Island is characterized by less dense rainforest and
sandier soil. Big Ngella is heavily forested, although commercial deforestation is common, and
smaller villages are encountered in the Bay area around Tulagi, the provincial capital. The
more remote northern villages of Big and Small Ngella and those on the southern coast are
larger. The communities of the Utuha Channel lay in an extensive mangrove system and are
smaller in size. There is minimal seasonal variation in temperature and despite a northwesterly
monsoon from November-April, the distinction between wet and dry season is not pro-
nounced. The most recent census estimates 26,051 inhabitants (approximately 60% of these re-
side in Ngella), 49% females and a median age of 19.9 years [20]. There is significant migration
between Ngella and other malaria endemic areas, in particular Honiara (Guadalcanal) and Ma-
laita provinces. These provinces are well connected to Ngella by a popular ferry service and nu-
merous private, unscheduled motorized boat trips. The Ngella population is serviced by a
hospital in Tulagi, six rural health sub-centres and ten nurse aid posts. National malaria statis-
tics describe Ngella as mesoendemic, with a reported Annual Parasite Index [21] of 46.1/1000
in 2012, P. falciparum being the main cause of malaria cases [6].
Overall API for Solomon Islands indicates that there were two transmission peaks in 2012
for the months of February and October. As elsewhere in the country, long lasting insecticidal
nets and indoor residual spraying are the mainstay of malaria control in Ngella. Cases are diag-
nosed by LM or RDT and treatment with artemether-lumefantrine has been introduced na-
tionally in 2008.
The last malaria epidemiological report of Ngella [7] described it as ‘the most malarious
group in all Solomon Islands” and the “most difficult from which to clear malaria”. Malario-
metric surveys preceding the Malaria Eradication Program (March 1965—January 1970, un-
published World Health Organisation Field Reports (reviewed in [8]) identified a combined
parasite rate of 69.6% and a spleen rate of 69.3% in the 2–9 years age group. In the same sur-
veys, villages on the North coast had spleen rates in the 80% range and qualified for the hyper-
endemic classification [7], whereas the villages in the Bay area and South coast were noted to
have had spleen rates in the 30–50% range [7].
Study population and blood sample collection
A representative population sample was obtained with a household-based sampling strategy of
villages in 5 distinct geographical regions (Fig 1B, Anchor Island, North Coast, Bay, South
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Coast and Channel). The survey included 3501 individuals of all ages6 months residing in
874 households in 19 randomly selected communities. The households were enumerated and
geo-positioned and demographic information of the male and female heads of the household
collected. Enumeration, but not geopositioning, was achieved for the households in the villages
of the South Coast. The timing of the survey was approximately 4 weeks after the peak of the
wet season.
Following consent and enrolment from each participant, a short clinical assessment was
conducted (including tympanic temperature, history of fever during the previous 48 hours, his-
tory of malaria in the last 2 weeks and spleen size in children 2–9 years old) and demographic
information collected (age, sex, residency status and history of travel, bed net use). A febrile
participant was defined as having a tympanic temperature38.0°C and/or a history of febrile
illness in the past 48 hours. Study participants who reported being ill at the time of the survey
Fig 1. Ngella sampling sites and spatial distribution of P. vivax prevalence (qPCR). The 9 island provinces of SI are shown in the top right inset. A
(inset). Central Islands Province. B (inset). Ngella. B. Ngella study catchments and prevalence. Anchor Island (catchments shown in yellow), Bay
(catchments in red), Channel (catchments in purple), North Coast (catchments in orange) and South Coast (catchments in blue). The size of the prevalence
pie chart reflects village sample size.
doi:10.1371/journal.pntd.0003758.g001
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were diagnosed by RDT (Access Bio, CareStart, USA) and treated if positive with artemether/
lumefantrine, as per the national treatment guidelines. Where available the participant’s health
records were checked for recent anti-malarial treatment and applicable information recorded.
A 250 μL finger prick blood sample was collected into EDTA-Microtainer tubes (Becton
Dickinson, NJ, USA). 50 μL were immediately stabilized in 250 μL RNAProtect (Qiagen, Ger-
many) for RNA studies and stored at ice pack cooling conditions until their transport to a cen-
tralized field laboratory. Thick and thin films were prepared for determination of microscopic
malaria infection. Haemoglobin measurement was performed with Hemocue HB 301 analyzer.
A measurement below 11g/dL was classified as anaemia. Upon return to the centralized labora-
tory, the RNAProtect fractions were frozen immediately. The remaining 200 μL of whole blood
was separated into red blood cells pellets and plasma and promptly frozen.
LM detection of Plasmodium spp. parasites
Giemsa stained blood films were examined under x1000 power. One hundred fields of view
were examined before calling a sample “no parasites seen”. When a parasite was observed,
counts of both white cells and parasites were commenced, and continued until 300 white cells
had been counted. The parasite count was then calculated, based on an assumed white cell
count of 8,000 white cells/ μL. However if no further parasites were observed, the process of
scanning to a total of 100 fields of view was completed. When only 1 parasite had been ob-
served in 100 fields of view, an assumed count at the notional lower limit of detection of 10 par-
asites/μL was applied, based on a further assumption of an average of 8 white cells per field of
view. All slides were stained within 24 hours at the regional malaria laboratory and read by ex-
perienced microscopists, all of whom had completed WHO quality assurance courses. All LM
positive slides as well as the slides from all PCR positive / LM negative plus 10% of LM & PCR
negative slides were re-read by an Australian Level 1 expert microscopist that was blinded to
the PCR results. None of the 10% LM negative slides were found to be positive by the expert
microscopist. In case of discrepancies between the two microscopy reads, the read of the expert
microscopist was considered final.
DNA and RNA extraction
Genomic DNA (gDNA) was isolated from red blood cell pellets (100 μL, corresponding to
200 μL whole blood) using FavorPrep 96-well Genomic DNA kit (Favorgen, Taiwan). DNA
was eluted in 200 μL elution buffer and stored at -20°C. The RNA isolation procedure from
whole blood in RNAProtect cell reagent has been described elsewhere [22], the only exception
being an increased elution volume of 60μL of RNase-free water. Due to problems with storage
of RNAProtect samples in the field, the quality of the RNA was tested using an RT-qPCR for
the human beta globin transcript [23]. This revealed a 10x lower total human RNA concentra-
tion than in samples from a comparable study in Papua New Guinea [24]. RNA samples were
therefore concentrated 10-fold using a CentriVap Concentrator (Labconco, United States) be-
fore testing for the presence of gametocytes.
Molecular detection of Plasmodium spp. parasites
All 3501 DNA samples were first screened using a genus-specific qPCR targeting a conserved
region of the 18S rRNA gene [22]. Singleplex species-specific P. falciparum and P. vivax Taq-
man qPCRs and a duplex P.malariae/P. ovale qPCR, targeting species-specific regions of 18S
rRNA gene, were used to identify species as described previously [22,25]. Prevalence values re-
ported in this study include only those infections confirmed by the species-specific qPCR Taq-
man assays. Each detection experiment carried a dilution series of plasmids containing the
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target sequence of each PCR (104, 103, 102, 101, 5, 100 copies/μL), in duplicate, and were used
to determine standard curves and therefore estimate parasite densities (reported as 18S rRNA
gene copy numbers/μL). All assays were run in 384-well plate format on the Roche LightCy-
cler480 platform. Those infections detected by qPCR, but not by LM, were defined as sub-mi-
croscopic infections. P. falciparum and P. vivax samples that were positive by species-specific
Taqman qPCR were examined for presence of gametocytes using RT-qPCRs targeting the
pfs25 and pvs25 orthologues, which are expressed only in mature gametocytes, as described
previously [22]. All gametocyte assays were also run in 384-well plate format on the Roche
LightCycler480 platform.
Plasmodium spp. genetic diversity
All samples that were P. falciparum or P. vivax positive were genotyped to determine the multi-
plicity of infection (MOI) using highly diverse size-polymorphic molecular markersmsp2 for
P. falciparum andmsp1F3 and MS16 for P. vivax, respectively. PCR and capillary electrophore-
sis were performed with slight modifications to the published protocols [26,27]. Genotyping
data was analyzed as described previously [26,27].
Statistical analysis
Study data were collected and managed using REDCap electronic data capture tools hosted at
the Walter and Eliza Hall Institute [28]. Analyses were done using the STATA12 statistical
software package (College Station, TX). Differences in participant characteristics at enrolment
and prevalence differences among geographical areas and groups of individuals were assessed
using Chi-square (χ2) or Fisher’s exact tests. Differences in median ages and median household
size were explored with quantile regression. Univariable and multivariable logistic regression
were used for associations of P. vivax infection and exposure variables. Associations with P.
vivax parasite density were investigated in simple and multivariable linear regression models
on only those subjects who tested positive to qPCR diagnosis. Poisson regression analyses were
utilized to explore associations between multiplicity of infection and exposure variables.
Results
Study population
A total of 3501 Ngella residents across 874 households were surveyed. The gender and age pro-
files of the participants were representative of the Central Islands Province population, with
52.5% females and a predominance of younger individuals (median age 18 years). The age dis-
tribution was as follows:<2 years, 4.7%; 2–4 years, 10.6%; 5–9 years, 14.8%; 10–14 years,
14.3%; 15–19 years, 7.5%; 20–39 years, 27.0%;>40 years, 21.3%. The majority of participants
(95.2%) resided in the village for 2 months. Of 447 participants who spent at least one night
outside their village of residence in the last month, 69.1% travelled within Central Islands Prov-
ince. 73.3% of participants reported having slept under a long lasting insecticidal net the night
before and 56.4% owned a bednet for longer than 24 months. Of all households, 84.5% of
households reported to have been sprayed with insecticide, and 70.4% of household heads
spoke English. Of all participants, 687 (19.4%) had a history of fever in the previous two days,
685 (19.7%) reported feeling unwell/sick at the time of survey and 23.3% had a haemoglobin
measurement<11g/dL. No participant aged 2–9 years of age was found to have an enlarged
spleen. A detailed description of demographic and clinical characteristics by geographical re-
gion is given in S1 Table.
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Prevalence of Plasmodium spp. infection by LM
Overall, 130 individuals (3.7%) had Plasmodium spp. parasites detectable by LM: 126 P. vivax,
three P. falciparummono-infections and one P. vivax/P. falciparummixed infection. No infec-
tions with P.malariae or P. ovale were observed. The prevalence of P. vivax infection varied
significantly by geographical region (p<0.001) (Fig 1B) and was lowest in the South Coast and
Anchor regions (0.8%), followed by Channel (3.0%) and Bay (3.5%) and North Coast (11.7%).
P. vivax prevalence showed strong age trends and peaked in adolescents 10–15 years of age
(8.6%, p<0.001) (Fig 2A).
Prevalence of P. vivax by qPCR
Overall, 468 participants (13.4%) had qPCR-detectable infections: 463 were P. vivaxmono-in-
fections and five were mixed P. falciparum/P. vivax infections (0.14%). The 126 P. vivax infec-
tions and the one mixed infection by LM were confirmed by qPCR. Overall, 72.9% of P. vivax
infections were sub-microscopic. In two of the catchments, Kelarekeha and Vuturua (Fig 1B),
only sub-microscopic infections were observed among 59 and 156 individuals surveyed, re-
spectively. P. vivax qPCR prevalence displayed spatial heterogeneity among the five geographi-
cal areas and the 19 catchments, varying from 3.0–38.5%. Prevalence by qPCR was highest in
villages on the North Coast (25.0–38.5%) and lowest on Anchor Island (3.0–5.5%) (Fig 1B).
Of 874 households sampled across Ngella, 559 had no infected members, 210 had only one
infected member and 105 had two or more infected members. There was no association be-
tween household size and probability of being infected (p = 0.550). Not taking into account any
other variables, there was an increased risk of being infected if at least one other member of the
household was infected (OR = 2.59, p<0.001, CI95[2.13, 3.16]).
P. vivax prevalence was age-dependent (p<0.001), lowest in<2 years (3.0%, n = 166) and
peaking in the 10–14 year old age group (24.3%, n = 499) (Fig 2A). Prevalence of infection did
not differ significantly between male and female participants (p>0.650). Participants who were
residents (lived in the village 2 months) were more frequently infected with P. vivax than
non-residents (infected residents: 13.7% vs. infected non-residents 8.3%, p = 0.045). Once resi-
dency status was taken into account, recent travel (defined as spending at least 1 night away
from the village of residence in the last month) was not associated with a difference in infection
risk (p = 0.300). Those living in a household where the household head speaks English, a proxy
for education level, were infected less frequently (12.0%) than those living in a household
where the head does not speak English (18.5%, p<0.001). There was a moderate increase in
risk of P. vivax infection in those who reported not having slept under a net the night before
compared to net users (users: 12.6% vs. non-users: 15.6%, p = 0.022).
The majority of P. vivax-infected individuals (84.6%) neither reported febrile symptoms
(defined as history of fever or measured fever at survey) nor feeling ill (85.4%). Six of the 26
participants that had a measured fever at the time of the survey (tympanic temperature38°C,
18.8%) were infected with P. vivax. Compared to uninfected participants, those with a P. vivax
infection were less likely to report having had febrile symptoms in the previous two days (unin-
fected 20.0% vs. infected 15.2%, p = 0.014) or report feeling unwell at the time of survey (unin-
fected 20.5% vs. infected 14.6%, p = 0.003). A total of 280 P. vivax infections (60.0%) were both
asymptomatic and sub-microscopic. There were no significant differences in the proportion of
asymptomatic P. vivax infections between different age groups (p> 0.200) and regions (p>
0.240). Of 468 P. vivax-infected individuals, 19.6% had a haemoglobin<11 g/dL compared to
23.9% of uninfected individuals (p = 0.045).
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Multivariable associations with P. vivax infection
Age was the strongest independent association with P. vivax. infection, peaking in 10–14 year
olds (Table 1, AOR = 8.41, p<0.001) and remaining relatively steady for subjects aged 15 years
and above (Table 1, 15–19 years AOR = 5.03; 20–39 years AOR = 4.75; 40 years AOR = 4.40;
p<0.001). The reference group in this analysis was composed of children aged<2 years. Being
a local resident, region of residency and living in a household with at least 1 additional infected
member were all associated with an excess risk of infection. Significant protective factors in-
cluded an English-speaking household head and reporting feeling unwell at the time of the sur-
vey. Detailed results are given in Table 1.
Fig 2. Age trends of P. vivax infections. A: P. vivax blood stage parasite prevalence by LM and qPCR (error bars represent binomial 95% confidence
intervals, CI95). B: P. vivax parasite densities by qPCR (18S DNA copies/l) and LM counts (parasites/l) (error bars represent 95% confidence intervals, CI95).
C: Gametocyte prevalence (in the total sampled population) and positivity (only among P. vivax infected) (error bars represent 95% confidence intervals,
CI95). D: P. vivaxmultiplicity of infection (MOI) of blood stage parasites (error bars represent 95% confidence intervals, CI95).
doi:10.1371/journal.pntd.0003758.g002
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P. vivax parasite densities
Parasite densities by LM count were low (estimated geometric mean 24.3 parasites/μL, CI95
[19.2, 30.8]) (Fig 2B). Of 130 LM-detectable infections, 55% (n = 70), were at the assumed limit
of practical detection, i.e. approximately 10 parasites/μL. Similarly, P. vivax parasite densities
by qPCR were also low (estimated geometric mean 18S DNA copy numbers of 4.6/μL, CI95
[3.9, 5.4]) (Fig 2B). In LM and qPCR positive infections, parasite density by LM (parasites/μL)
and by qPCR (18S DNA copies/μL) were correlated (n = 130, R2 = 0.76, p<0.001). Factors pre-
dicting parasite densities by qPCR included age, history of fever in the preceding two days,
anaemia (haemoglobin<11 g/dL) and geographical region of sampling. Parasite densities were
highest among individuals aged<2 years and decreased in older age groups (p<0.001). De-
tailed results of associations with P. vivax density are given in Table 2.
P. vivax genetic diversity
Genotyping results for markersmsp1F3 and/or MS16 were obtained from 349 P. vivax positive
samples. Both markers were highly diverse; 15msp1F3 alleles and 43 MS16 alleles were de-
tected (Fig 3), resulting in an expected heterozygosity (HE) of 0.834 formsp1F3 and 0.937 for
MS16. Out of 349 samples, 102 (29.2%) carried multi-clonal infections. MOI (combined
msp1F3 and MS16), defined as the concurrent infections per individual, ranged from 1 to 4;
mean MOI was 1.36. Mean MOI did not differ significantly among age groups (Fig 2D, p =
0.774) or among geographical regions (p = 0.610). P. vivax-infected individuals living in a
Table 1. Multivariable associations with P. vivax infection.
n PR AOR CI95 p-valuea
Region Bay 1,161 13.7 Reference group
Channel 463 13.2 1.01 [0.71, 1.44] <0.001
Anchor 857 3.9 0.28 [0.18, 0.44]
North Coast 523 31.7 2.52 [1.90, 3.34]
South Coast 497 9.9 0.74 [0.52, 1.06]
Age group (years) <2 166 3 Reference group
2–4 370 5.4 1.90 [0.68, 5.30] <0.001
5–9 517 15.1 5.46 [2.13, 14.01]
10–14 499 24.3 8.41 [3.31, 21.38]
15–19 263 14.5 5.03 [1.88, 13.40]
20–39 940 12.6 4.75 [1.88, 12.02]
40 746 11.8 4.40 [1.72, 11.23]
Head of the household speaks English No 661 18.5 Reference group
Yes 2,465 12 0.76 [0.50, 0.98] 0.030
Feeling unwell No 685 14.3 Reference group
Yes 2,793 9.9 0.65 [0.48, 0.89] 0.001
Residency (lived in the village for 2 or more months) No 169 8.3 Reference group
Yes 3,317 13.7 1.91 [1.05, 3.48] 0.004
Living in a household with at least 1 other P. vivax carrier No 2,235 63.8 Reference group
Yes 1,266 36.2 1.75 [1.39, 2.20] <0.001
n = sample size, PR = prevalence of P. vivax infection, AOR = adjusted odds ratio (predicted difference in odds of P. vivax infection compared to the
baseline odds of P. vivax infection of the reference group), CI95 = 95% confidence intervals.
aOverall p-values for variables with multiple levels (age group and region) were derived by use of the likelihood ratio test comparing expanded (includes
variable of interest) and nested (does not include variable of interest) models. P-values for the remaining variables are derived from the Wald test.
doi:10.1371/journal.pntd.0003758.t001
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household with at least one other infected individual had moderately higher mean MOI (1.56)
than those who were the sole infected person of the household, but evidence for an association
was moderate to weak (mean MOI = 1.42, p = 0.086). Mean MOI was positively associated
with qPCR parasite density (p = 0.007).
P. vivax RT-qPCR gametocyte prevalence
In 110 of 468 (23.5%) P. vivax infections, gametocytes were detected by the pvs25 RT-qPCR, re-
sulting in a population gametocyte prevalence of 3.14%. More gametocytes were detected in
LM-positive (41.5%) than sub-microscopic infections (16.6%, p<0.001). The proportion game-
tocyte positive (defined as percentage of gametocytaemic P. vivax carriers) was highest in the
2–9 year olds (39.8%, n = 98) and decreasing sharply in the 10–14 year olds (20.7%, n = 121,
p>0.001). The lowest proportion gametocyte positive was found among the P. vivax carriers in
the 15–19 years and>40 years age groups (15.8%, n = 38 and 15.9%, n = 88, respectively)
(Fig 2C).
Table 2. Multivariable associations with P. vivax density estimates by qPCR.






Region Bay 1161 2.98 Reference group
Channel 463 4.73 0.12 [-0.09,
032]
<0.001




523 6.21 0.25 [0.09, 0.40]
South
Coast
497 7.64 0.45 [0.22, 0.67]
Age group (years) <2 166 20.88 Reference group
2–4 370 8.99 -0.19 [-0.89,
0.50]
<0.001
5–9 517 11.28 -0.1 [-0.75,
0.54]
10–14 499 4.97 -0.41 [-1.05,
0.24]
15–19 263 3.67 -0.52 [-1.19,
0.15]
20–39 940 2.99 -0.62 [-1.26,
0.02]
40 746 3.03 -0.67 [-1.31,
-0.02]
Fever in the last two days No 2798 4.39 Reference group
Yes 675 6.29 0.2 [0.01, 0.39] 0.036
Anaemia (haemoglobin<11 g/dL) No 2682 4.01 Reference group
Yes 815 8.46 0.2 [0.03, 0.37] 0.023
§The regression coefficients represent the predicted changes in 10-fold parasite density (estimated as 18S DNA copies/μL) compared to the mean
parasite density of the reference group.
aOverall p-values for variables with multiple levels (age group and region) were derived by use of the likelihood ratio test comparing expanded (i.e.
including the variable of interest) and nested (not including the variable of interest) models. P-values for the remaining variables are derived from the
Wald test.
doi:10.1371/journal.pntd.0003758.t002
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P. falciparum infection
By qPCR, P. falciparum was detected in 5 individuals, all of whom were co-infected with P.
vivax. Of these, only four infections were detectable by LM, one as a co-infection with P. vivax
and three as P. falciparummono-infections. In two of the LMmono-infections and the mixed
infection, only P. falciparum gametocytes were observed on the blood smear. The range of par-
asite densities, by qPCR, was 7.35–364 copy numbers/μL and in LM positive samples the densi-
ties ranged from 20 to 1430 parasites/μL. The low number of P. falciparum infections
precluded analyses with densities for this species. The presence of gametocytes in the four LM-
positive infections was confirmed by pfs25 RT-qPCR. No gametocytes were detected in the one
sub-microscopic P. falciparum infection by RT-qPCR.
All five P. falciparum-infected individuals resided in the same village (Halavo, circled in Fig
1B) and ranged in age from 3 to 60 years. The oldest had a history of fever in the preceding two
days. Two of the carriers had a haemoglobin measurement<11g/dL. None of the individuals
reported to have slept outside the village in the previous month. All five P. falciparum infec-
tions were monoclonal and carried the samemsp2 genotype of the Fc27 subtype.
Discussion
Solomon Islands has achieved a remarkable 90% reduction in malaria incidence over the last
two decades as a result of scaled-up malaria control interventions [6] and is now intensifying
its efforts towards malaria elimination [3]. The present study is the first to undertake sensitive
molecular diagnosis at this scale in Solomon Islands and the first large epidemiological descrip-
tion of malaria in Ngella since the Malaria Eradication Program (1970–1975). Our findings il-
lustrate a striking distinction between the epidemiology of P. falciparum and P. vivax in Ngella.
High prevalence (13.4% by qPCR) and genetic diversity, as well as an increased risk for local
residents and evidence of potential within-household transmission indicate considerable levels
of endemic P. vivax transmission. There was significant variation of P. vivax transmission in
different regions of Ngella, with the highest prevalence found on the remote North Coast
Fig 3. Diversity of P. vivax genotypic markersmsp1F3 and MS16. Allelic frequencies of P. vivax msp1F3, MS16 and the combinedmsp1F3 / MS16
haplotypes. Formsp1F3 and MS16, the frequency of the four most common alleles and respective sizes (in basepairs) are shown. The number of unique
alleles identified and the estimated expected heterozygosity (HE) are given below the figure.
doi:10.1371/journal.pntd.0003758.g003
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(25.0–38.5%), which prior to the Malaria Eradication spraying operations was described as
holoendemic and having an environment highly favourable to the mosquito [7]. The lowest
rates of P. vivax infection were observed on Anchor (3.9% by qPCR), where 15 years ago a
community-based initiative eliminated a substantial number of breeding sites through environ-
mental management [Lodo, personal communication]. It is therefore likely that the presence of
suitable larval habitats and vector abundance may be key factors influencing P. vivax transmis-
sion on Ngella.
It remains unclear whether autochthonous P. falciparum transmission remains in Ngella or
parasites are being re-introduced by incoming travelers or returning residents from areas with
higher P. falciparum burden, such Guadalcanal or Malaita provinces. In this survey, only five
P. falciparum cases were identified in the village of Halavo (Fig 1B). As all five infections car-
ried the samemsp2 allele and four were gametocytaemic, a small local outbreak following re-
cent re-introduction seems more likely. This is reminiscent of the situation in epidemic-prone
areas of the Papua New Guinea highlands, where a clonal P. falciparum epidemic on a back-
ground of endemic, low level P. vivax transmission has been reported [29]. P. falciparum popu-
lations in neighbouring Guadalcanal province were in fact found to be of low genetic diversity
[30,31]. Based on case statistics at the local health facilities, 30% of malaria cases detected in
Central Islands Province are caused by P. falciparum [6] indicating that either importation of
P. falciparum parasites is common or that low levels of endemic P. falciparum transmission
may remain in some parts of Ngella. Further studies are therefore required to ascertain the ab-
sence of endemic P. falciparum transmission in this area of Solomon Islands and whether the
cases found are the result of inter-island travel.
The current situation of malaria in Ngella (i.e. 3.7% prevalence by LM, clear P. vivax domi-
nance and absence of enlarged spleens in children 2–9yrs of age) is a consequence of the dra-
matic reduction in malaria transmission achieved throughout Solomon Islands in the last 20
years [6]. This change is similar to that encountered at the end of 1974, after approximately 5
years of twice-yearly Malaria Eradication Program spraying. Then, prevalence in 2–9 year olds
had dropped from pre-spraying rates of 60% to 1.4% and P. vivax became predominant [7].
Similar shifts in malaria epidemiology were also observed in the elimination provinces of
Temotu [9] and Isabel [8]. In Temotu, P. falciparum accounted for 17.5% of infections in popu-
lation survey conducted in 2008 [9], but by 2012, the national program’s surveillance system
reported only P. vivax cases from both Temotu and Isabel [6]. This shift in the relative impor-
tance of P. falciparum and P. vivax are not unique to Solomon Islands and have been reported
after periods of sustained malaria control from other settings where P. falciparum and P. vivax
occur sympatrically, such as the Amazon [21,32], Central America [4] and Thailand [33].
As in other endemic settings [12,13,34], P. vivax infections were of low density and PCR
found three times more infections than LM. The majority of infections were not accompanied
by febrile symptoms or anaemia. On the contrary, participants who reported feeling unwell or
febrile were less likely to be infected with P. vivax. While this significantly lower level of febrile
symptoms in P. vivax carriers is likely to be an artifact of the large samples size it does indicate
that P. vivax is not a common cause of fever in Ngella. Whereas asymptomatic P. vivax infec-
tions have been commonly found in areas of high transmission [12,35,36], the advent of molec-
ular diagnosis has revealed that even at low transmission the majority of infections in cross-
sectional surveys are symptomless [11,37,38], including in the previous surveys in Temotu [9]
and Isabel [8] where 97.1% and 92.9% of P. vivax infected individuals infections were asymp-
tomatic, respectively.
Both the presence of P. vivax infections and their level of parasitaemia were found to be
strongly age-dependent, albeit in different ways: while P. vivax parasite densities decreased
with age, prevalence of P. vivax infections rose throughout childhood and only started
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dropping in adolescents and adults. These contrasting patterns are most likely due to local
mosquito biting behavior and acquisition of immunity. Anopheles farauti, the only coastal ma-
laria vector in Solomon Islands, is biting predominantly in the early evening (i.e. before 10pm)
and outdoors [39], when small children tend to be indoors but older ones still active. The in-
crease in prevalence during childhood is thus likely to represent an increase in exposure to in-
fective bites. At all levels of transmission, immunity to P. vivax tends to be more rapidly
acquired than that to P. falciparum [40]. Thus, the strong reduction in prevalence and parasite
densities with increasing age in Ngella indicate that P. vivax transmission there remains suffi-
ciently high for relatively rapid acquisition of clinical and anti-parasite immunity.
Despite very low overall parasite densities, gametocytes were detected in almost a quarter of
all P. vivax infections (in 41.5% of LM-positive infections and 16.6% of sub-microscopic infec-
tions). Given issues with RNA quality, it is likely that the gametocytaemic reservoir in Ngella
was underestimated in our survey and the true prevalence of gametocytes is higher, especially
in the sub-microscopic group. Given the rapid and ongoing production of P. vivax gameto-
cytes, most if not all, blood stage infections could harbor concurrent gametocytes [41]. Whilst
sub-patent P. falciparum infections have been shown to infect up to 43.5% of mosquitoes
[17,19], the role of sub-microscopic P. vivax gametocyte carriage in sustaining transmission is
poorly understood. The capacity of sub-microscopic P. vivax infections to infect mosquitoes
has been established in studies from Thailand [18,42,43], Sri Lanka [44], Peru [45] and malaria
therapy settings [14,15], but at varying proportions and with weak associations of gametocyte
density. Although sub-patent infections may infect fewer mosquitoes, their higher prevalence
in endemic settings may mean that the net transmission potential of low-density infections is
higher. In Ngella, asymptomatic, sub-microscopic infections of adolescents and adults may
thus be an important source of local transmission.
These considerations may constitute a significant challenge to the success of the Solomon
Islands malaria control program. The national malaria surveillance system, based on passive
case detection and irregular mass blood surveys, only employs traditional microscopy diagno-
sis. This diagnostic test may not only underestimate the true burden of malaria in the Solomon
Islands but also lack the means to detect and attack a substantial part of the P. vivax transmis-
sion reservoir. Despite outstanding gains in the last two decades, traditional tools of the Solo-
mon Islands malaria control program may therefore have reached their effectiveness in the
face of a large and silent reservoir of P. vivax infection.
Our observation that people living in a household with another P. vivax infected individual
is a noteworthy finding. Not only does it indicate likely within-household transmission, but
also highlights that reactive case detection strategies [46–48] and focal mass drug administra-
tion [34] might be appropriately applied in Solomon Islands. In the Southwest Pacific, MDA
campaigns that included primaquine to target the undetectable liver stage parasites have previ-
ously been successful in interrupting P. vivax transmission on Aneytium Island in Vanuatu
[49] and Nissan Island in Papua New Guinea [50]. Combining automated registration of ob-
served cases and rapid identification of transmission foci (e.g. in a spatial decision support sys-
tem) [51] with reactive mass-screen and treat (MSAT) or with focal, household-based mass
drug administration [52,53] should therefore be evaluated as possible additional malaria elimi-
nation tools in Solomon Islands and neighbouring Vanuatu. All interventions will be most
efficacious if they include routine administration of primaquine to all P. vivax infected individ-
uals. This will however require addressing the challenges posed by the potential primaquine
toxicity in G6PD deficient individuals.
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